14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.10 $80.02 Thursday, 10th Nov 2022 EPZM stock ended at $1.47. During the day the stock fluctuated 0% from a day low at $1.47 to a day high of $1.47.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Epizyme prices

Date Open High Low Close Volume
Jun 28, 2019 $12.18 $12.62 $11.95 $12.55 3 465 179
Jun 27, 2019 $12.83 $12.96 $12.12 $12.20 1 323 200
Jun 26, 2019 $13.32 $13.71 $12.58 $12.85 1 114 094
Jun 25, 2019 $14.92 $14.92 $13.15 $13.29 2 066 976
Jun 24, 2019 $15.00 $16.59 $14.91 $15.12 1 792 312
Jun 21, 2019 $13.67 $15.13 $13.46 $14.97 2 729 229
Jun 20, 2019 $13.25 $13.82 $13.20 $13.51 832 871
Jun 19, 2019 $13.05 $13.28 $12.79 $13.25 643 554
Jun 18, 2019 $12.50 $13.10 $12.45 $13.05 752 716
Jun 17, 2019 $11.75 $12.44 $11.75 $12.42 1 113 789
Jun 14, 2019 $11.97 $12.16 $11.52 $11.63 669 357
Jun 13, 2019 $12.10 $12.56 $11.81 $12.00 1 153 257
Jun 12, 2019 $14.01 $14.07 $12.01 $12.10 1 910 969
Jun 11, 2019 $14.43 $14.81 $13.99 $14.03 897 517
Jun 10, 2019 $14.35 $14.47 $14.07 $14.31 625 780
Jun 07, 2019 $13.49 $14.24 $13.36 $14.22 744 321
Jun 06, 2019 $13.49 $13.83 $13.15 $13.49 889 424
Jun 05, 2019 $13.65 $13.69 $13.16 $13.43 1 030 050
Jun 04, 2019 $14.09 $14.12 $13.37 $13.62 714 481
Jun 03, 2019 $13.76 $14.18 $13.63 $13.89 1 055 903
May 31, 2019 $13.85 $14.28 $13.70 $13.74 488 097
May 30, 2019 $13.85 $14.78 $13.85 $13.93 923 469
May 29, 2019 $13.19 $13.78 $13.10 $13.65 1 550 407
May 28, 2019 $12.96 $13.50 $12.90 $13.38 648 525
May 24, 2019 $12.55 $13.05 $12.42 $12.93 1 054 720
Click to get the best stock tips daily for free!

About Epizyme

Epizyme Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma; and PARP inhibitor in pa... EPZM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT